Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit for Accurate Viral Identification

In the field of modern molecular diagnostics, rapid and accurate pathogen detection has become a cornerstone of effective clinical decision-making and infectious disease control. Enteroviruses, particularly EV71 and CoxA16, are well-known causes of hand, foot, and mouth disease (HFMD), which can lead to serious complications in children and vulnerable populations. Early and precise identification of these pathogens is essential for timely treatment and epidemic prevention.

Cowin Gene is dedicated to advancing molecular POCT (Point-of-Care Testing) technology, providing clinicians and patients with fast, reliable, and highly sensitive diagnostic solutions. With PCR-based core technology, Cowin Gene’s product line enables the rapid detection of viruses, bacteria, and fungi, significantly improving diagnostic efficiency in clinical environments.

The company brings together a team of senior scientists, engineers, and marketing experts who are committed to continuous innovation and product optimization. Its R&D center is equipped with advanced laboratory instruments and a strict quality management system, ensuring that every product meets international standards. Cowin Gene aims to become a global innovation leader in molecular POCT in vitro diagnostics, contributing to improved human health worldwide.

Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit for Accurate Viral Identification

The Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit is an in vitro diagnostic (IVD) PCR-based assay designed for the qualitative detection of RNA from Enterovirus Universal, EV71, and CoxA16 in patient specimens. It enables simultaneous detection of multiple viral targets in a single analysis, improving diagnostic efficiency and reducing turnaround time.

This kit is particularly valuable in clinical settings where rapid identification of enterovirus infections is critical. By accurately distinguishing EV71 and CoxA16, it helps clinicians make informed treatment decisions and supports public health monitoring during outbreaks.

The assay utilizes real-time PCR amplification technology, ensuring high specificity and sensitivity. With a limit of detection (LoD) as low as 400 copies/mL for all targets, it provides reliable results even in low viral load samples.

High-Sensitivity EV71 and CoxA16 Detection Kit (Liquid) for Clinical Laboratory Use

This liquid-form PCR detection kit is optimized for high-sensitivity viral RNA detection in clinical laboratories. It is designed to identify Enterovirus Universal, EV71, and CoxA16 with exceptional accuracy, making it suitable for early-stage infection screening and outbreak control.

The kit supports validated specimen types including oropharyngeal swabs and herpes fluid swabs, ensuring flexibility in sample collection. Its compatibility with open real-time PCR instruments such as ABI 7500, Roche 480, and Bio-Rad CFX96 makes it highly adaptable to existing laboratory workflows.

With CE-IVD certification, the product meets stringent international regulatory standards, ensuring consistent performance and reliability in professional diagnostic environments.

Rapid Enterovirus Universal Detection Kit for Reliable Infectious Disease Screening

This rapid detection kit is designed to accelerate the screening process for enterovirus infections while maintaining high diagnostic accuracy. It enables simultaneous detection of multiple viral strains in a single reaction, reducing laboratory workload and improving efficiency.

The kit’s PCR-based amplification system ensures precise RNA detection, allowing early identification of infections even at low viral concentrations. This is particularly important in preventing the spread of hand, foot, and mouth disease in community and hospital settings.

Cowin Gene’s advanced molecular technology ensures that each batch of reagents undergoes strict quality control, providing stable performance and reproducible results across different testing environments.

Professional Molecular Diagnostic Kit for EV71, CoxA16 and Enterovirus Detection

This professional molecular diagnostic kit is developed for comprehensive viral screening in clinical laboratories and public health institutions. It provides reliable detection of Enterovirus Universal, EV71, and CoxA16 in a single integrated assay, improving diagnostic efficiency and reducing the need for multiple tests.

The kit is designed with high stability and long shelf life, supporting storage at ≤-20℃ for up to 18 months. It also maintains transport stability for up to 15 days under controlled conditions, ensuring product integrity during global distribution.

Strict storage and handling requirements, including protection from light, controlled freeze-thaw cycles, and proper reagent preparation, ensure optimal performance and accuracy during testing procedures.

Cowin Gene’s molecular POCT products provide significant advantages in clinical diagnostics, including rapid detection time, simplified operation procedures, and high sensitivity performance. These features make them highly suitable for hospitals, laboratories, and emergency diagnostic scenarios.

The company’s core product portfolio is based on PCR technology, enabling the detection of a wide range of pathogens including viruses, bacteria, and fungi. Each product is developed under a strict quality management system to ensure compliance with international diagnostic standards.

The Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit is supported by additional recommended reagents, including viral DNA/RNA extraction kits and column-based purification systems, ensuring complete workflow compatibility and optimized detection efficiency.

Cowin Gene continues to invest in research and development to enhance molecular diagnostic technologies. Its dedicated R&D center, equipped with advanced instruments and expert teams, ensures continuous innovation and product improvement.

With a strong commitment to global health, Cowin Gene aims to transform molecular POCT diagnostics by providing fast, accurate, and accessible testing solutions worldwide. The company envisions a future where rapid molecular detection becomes a standard tool in disease prevention and healthcare management, improving outcomes for patients across the globe.